FAKTOR OPTIONSSCHEIN - INCYTE CO. Share Price

DE000GG08UK9

Market Closed - BOERSE MUENCHEN 19:25:08 17/05/2024 BST
6.464 ^EUR	-1.04%

Current month	-22.45%
1 month	-17.90%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart INCYTE CORPORATION

Latest news about INCYTE CORPORATION

Transcript : Incyte Corporation Presents at Bank of America Health Care Conference 2024, May-15-2024 08:00 AM	05-15
Incyte to Highlight Data From its Oncology Portfolio at the 2024 ASCO Annual Meeting and EHA2024 Congress	05-14	BU
Equities Close Mixed as Markets Weigh Consumer Inflation Survey	05-13	MT
Equities Close Mixed as Markets Parse Consumer Inflation Survey	05-13	MT

More news

Quotes 5-day view

Date	Price	Change
17/05/24	6.464	-1.04%
16/05/24	6.532	+1.40%
15/05/24	6.442	-0.82%
14/05/24	6.495	-0.46%
13/05/24	6.525	-16.04%

Real-time BOERSE MUENCHEN

Last update May 17, 2024 at 07:25 pm

More quotes

Static data

Product type	Exotic Products
Buy / Sell	CALL
Underlying	INCYTE CORPORATION
Issuer	Goldman Sachs
WKN	GG08UK
ISIN	DE000GG08UK9
Date issued	27/11/2023
Strike	85.29 $
Maturity	Unlimited
Parity	4.02 : 1
Emission price	8.35 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	8.773 €
Lowest since issue	5.057 €
Spread	0.02 €
Spread %	0.31%

Company Profile

Incyte Corporation specializes in the research & development of therapeutic products mainly intended for the treatment of cancers and inflammatory disorders. Net sales break down by revenue source as follows: - product sales (85.6%); - royalties (14.2%); - income from research and cooperation agreements (0.2%).

Sector

More about the company

Ratings for Incyte Corporation

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Consensus: Incyte Corporation

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

57.1 USD

Average target price

73.35 USD

Spread / Average Target

+28.46%

Consensus